News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Hitachi Chemical Co., Ltd. Developed Novel Molecular Testing System for Personalized Medicine – Novel mRNA Quantitative Assay for Biomarker Discovery and Prediction of Drug Efficacy


11/15/2012 10:05:10 AM

TOKYO--(BUSINESS WIRE)--Hitachi Chemical Co., Ltd. (TOKYO:4217)(Head Office: Tokyo; President and CEO: Kazuyuki Tanaka; Capital: 15.5 billion yen; hereinafter referred to as "Hitachi Chemical"), in the field of life sciences, developed a novel mRNA quantitative assay called "Hem(A)+ System"i. This is a simple, high-throughput, reproducible method, that offers a wide range of applications in clinical biomarker discovery and molecular testing to target personalized medicineii.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES